Virios Therapeutics Inc. (NASDAQ: VIRI)
$0.25
-0.0025 ( -1.00% ) 1.2M
Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia ("FM") and Long-COVID ("LC"). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
Market Data
Open
$0.25
Previous close
$0.25
Volume
1.2M
Market cap
$6.78M
Day range
$0.24 - $0.26
52 week range
$0.16 - $2.24
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jun 20, 2024 |
8-k | 8K-related | 13 | Jun 12, 2024 |
8-k | 8K-related | 74 | May 20, 2024 |
10-q | Quarterly Reports | 52 | May 10, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
8-k | 8K-related | 13 | May 07, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
def | Proxies and info statements | 4 | Apr 25, 2024 |
10-k/a | Quarterly Reports | 61 | Mar 08, 2024 |
8-k | 8K-related | 14 | Mar 06, 2024 |